GlassScriptPhysician profile
Daniel J Henery
NPI 1932606407
$885.57
in general payments reported to CMS, 2019-2025
15 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $187 · 2023: $110 · 2024: $192 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $200.89 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $124.37 | 2022-2023 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.16 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $80.55 | 2025 | Lokelma |
| Novartis Pharmaceuticals Corporation | $51.87 | 2025 | |
| Heartflow, INC. | $51.03 | 2025 | |
| Boston Scientific Corporation | $48.62 | 2024 | Versacross Access Solution |
| E.R. Squibb & Sons, L.L.C. | $39.84 | 2024-2025 | Camzyos |
| Penumbra, INC. | $34.89 | 2024 | Penumbra Coil 400 |
| Teleflex LLC | $32.22 | 2024-2025 | Supercross, Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $30.97 | 2024 | Arcalyst |
| United Therapeutics Corporation | $28.53 | 2022 | |
| Cvrx, INC. | $20.84 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.23 | 2025 | Jardiance |
| Bridgebio Pharma, INC. | $13.56 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Henery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.